Aptorum Group plans 1-for-10 reverse stock split ahead of DiamiR merger
APM•Share counts and par value to change
Outstanding Class A shares would fall to about 634,682 from about 6,346,823.
Outstanding Class B shares would fall to about 179,693 from about 1,796,934.
The par value for both share classes would rise to $0.0001 from $0.00001, and the authorized share count would be reduced.
Reverse split planned before merger close
Aptorum Group plans to execute a 1-for-10 reverse stock split tied to its planned merger with DiamiR Biosciences, expected to close around July 20, 2026.
The split is intended to lift the post-merger share price to support Nasdaq minimum bid compliance. The combined company is set to trade as Niki BioSolutions under the ticker “NIKI”.
